New insights into oxygen sensing at a cellular level

Thorax

Volumn 59, Issue 2, 2004, Pages 90-92

  Walmsley, S R ^a   Sheares, K K K ^a   Sobolewski, A ^a   Morrell, N W ^a   Chilvers, E R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN;

ANGIOGENESIS; ASSOCIATION; CELL COMPOSITION; CELL FUNCTION; CONCENTRATION (PARAMETERS); EDITORIAL; HUMAN; HYPOXEMIA; INFLAMMATORY CELL; ISCHEMIA; LUNG CARCINOMA; LUNG DISEASE; LUNG TRANSPLANTATION; LUNG TUMOR; MEDICAL RESEARCH; NONHUMAN; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; REPERFUSION INJURY;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; CELL HYPOXIA; DNA-BINDING PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUNG DISEASES; MICE; OXYGEN; RECEPTORS, ARYL HYDROCARBON; TRANSCRIPTION FACTORS;

EID: 1242351728     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.2003.017020     Document Type: Editorial

References (22)

1. Siesjo BK. Cell damage in the brain: a speculative synthesis. J Cereb Blood Flow Metab 1981;1:155-85.
2. Lahiri S, Rozanov C, Roy A, et al. Regulation of oxygen sensing in peripheral arterial chemoreceptors. Int J Biochem Cell Biol 2001;33:755-74.
3. Goldberg MA, Dunning SP, Bunn HF. Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 1988;242:1412-5.
4. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene. Mol Cell Biol 1992;12:5447-54.
5. 2 tension. Proc Natl Acad Sci USA 1992;92:5510-4.
6. Wenger RH, Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 1997;378:609-16.
7. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-80.
8. 2- regulated gene expression. FASEB J 2002;16:1151-62.
9. Epstein ACR, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001;107:43-54.
10. 2-regulated prolyl hydroxylation. Science 2001;292:468-72.
11. Lando D, Peet DJ, Whelan DA, et al. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002;295:858-61.
12. Mahon PC, Hirota K, Semenza GL. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression ol HIF-1 transcriptional activity. Genes Dev 2001;15:2675-86.
13. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-15.
14. Maltepe E, Schmidt JV, Baunoch D, et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997;386:403-7.
15. Yu AY, Shimoda LA, Iyer NV, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxiainducible factor 1-alpha. J Clin Invest 1999;103:691-6.
16. Maxwell PH, Dachs GU, Gleadle JM, et al. Hypoxia-inducible factor-1 modulates gene expression in solid rumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA 1997;94:8104-9.
17. Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in radiotherapy of oropharyngeal cancer. Cancer Res 2001;61:2911-6.
18. Unruh A, Ressel A, Mohamed HG, et al. The hypoxia-inducible factor-1 alpha is a negative factor for tumour therapy. Oncogene 2003;22:3213-20.
19. Mecklenburgh KI, Walmsley SR, Cowburn AS, et al. Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood 2002;100:3008-11.
20. Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 2003;112:645-57.
21. Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischaemia-reperfusion injury. Circulation 2003;108:79-85.
22. Ehreneich H, Hasselblatt M, Dembowski C, et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002;8:495-505.